Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.

Novel 2-thioxothiazole derivatives (6-19) as potential adenosine A2A receptor (A2AR) antagonists were synthesized. The strong interaction of the compounds (6-19) with A2AR in docking study was confirmed by high binding affinity with human A2AR expressed in HEK293T cells using radioligand-binding assay. The compound 19 demonstrated very high selectivity for A2AR as compared to standard A2AR antagonist SCH58261. Decrease in A2AR-coupled release of endogenous cAMP in treated HEK293T cells demonstrated in vitro A2AR antagonist potential of the compound 19. Attenuation in haloperidol-induced impairment (catalepsy) in Swiss albino male mice pre-treated with compound 19 is evocative to explore its prospective in therapy of PD.

[1]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[2]  L. Robertson,et al.  Receptor interactions by polybrominated diphenyl ethers versus polychlorinated biphenyls: a theoretical Structure-activity assessment. , 2008, Environmental toxicology and pharmacology.

[3]  A. Rolland,et al.  Phenolic thiazoles as novel orally-active neuroprotective agents. , 2004, Bioorganic & medicinal chemistry letters.

[4]  G. Cutter.  Statistical issues in neutralizing antibodies , 2003, Neurology.

[5]  D. Tulshian,et al.  6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists. , 2005, Bioorganic & medicinal chemistry letters.

[6]  C. B. Mishra,et al.  Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists. , 2010, Bioorganic & medicinal chemistry letters.

[7]  G. Spalluto,et al.  Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists. , 1996, Journal of medicinal chemistry.

[8]  T. Shindou,et al.  The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[10]  G. Spalluto,et al.  7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility. , 2002, Journal of medicinal chemistry.

[11]  P. Lestage,et al.  In vivo neuroprotective effects of the novel imidazolyl nitrone free-radical scavenger (Z)-alpha-[2-thiazol-2-yl)imidazol-4-yl]-N-tert-butylnitrone (S34176). , 2005, European journal of pharmacology.

[12]  E. Ongini,et al.  Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation , 2003, Neurology.

[13]  C. B. Mishra,et al.  Novel 8-(furan-2-yl)-3-benzyl thiazolo [5,4-e][1,2,4] triazolo [1,5-c] pyrimidine-2(3H)-thione as selective adenosine A2A receptor antagonist , 2011, Neuroscience Letters.

[14]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[15]  C. B. Mishra,et al.  Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A(2A) receptor antagonists. , 2010, Bioorganic & medicinal chemistry.

[16]  J. Hubble,et al.  Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD , 2003, Neurology.

[17]  A. Ludolph,et al.  Protective Effects of Riluzole on Dopamine Neurons , 2000, Journal of neurochemistry.